SIRT1 and Wilson disease: Our data demonstrate Sirt1 overexpression protects against WD associated glucose intolerance (Figure 5a) and this metabolic effect may be a contributor to the protection against arterial stiffening either through modulation of vascular tone via endothelial function or through changes to the matrix that may involve advanced glycated end products.